Filed: 25 May 21, 8:05am






 Washington, D.C. 20549






Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): May 25, 2021



(Exact name of registrant as specified in its charter)


Delaware 001-38389 81-4042793
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation)   Identification No.)


1301 East Broward Boulevard, 3rd Floor

Ft. Lauderdale, FL

(Address of principal executive offices) (Zip Code)


Registrant’s telephone number, including area code: (954) 541-8000


Not Applicable
(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).


Emerging growth company ☒


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒ 


Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class Trading Symbol(s) Name of Each Exchanged on Which Registered
Common Stock, $0.0001 par value per share MOTS The Nasdaq Capital Market







Item 7.01. Regulation FD.


On May 25, 2021, Motus GI Holdings, Inc. (the “Company”) issued a press release announcing that Sinai Hospital of Baltimore, a LifeBridge Health center, will move ahead with fully adopting the Pure-Vu® System. A copy of the press release is attached hereto as Exhibit 99.1.


The information in this Current Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by a specific reference in such filing.


Item 8.01 Other Events.


On May 25, 2021, the Company announced that Sinai Hospital of Baltimore, a LifeBridge Health center, will move ahead with fully adopting the Pure-Vu® System with the aim of improving efficiencies and clinical outcomes of inpatient colonoscopy procedures for patients who present with inadequate bowel preparation.


Sinai Hospital of Baltimore treats many patients coming from nursing facilities with significant comorbidities, which can often make bowel preparation difficult. During the evaluation period, the Company was able to showcase the Pure-Vu System’s value proposition by enabling patient cases to proceed on time, despite suboptimal prep. The Company believes engaging with Sinai Hospital of Baltimore is a key milestone for its sales program, as it will be the first hospital within the LifeBridge Health system to adopt the Pure-Vu System. As previously disclosed, the Company is expanding its commercial focus to include large regional, multi-center integrated delivery networks.


Item 9.01. Financial Statements and Exhibits.


(d) The following exhibit is furnished with this report:


Exhibit No. Description
99.1 Press Release issued by Motus GI Holdings, Inc., dated May 25, 2021.






Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: May 25, 2021By:/s/ Timothy P. Moran
 Name:  Timothy P. Moran
 Title:Chief Executive Officer